ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 132313 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 132313; 2) Community: the network communities that were significantly associated with the response to NSC 132313; 3) Molecule: the relationships between components within communities and NSC 132313; 4) MDR: the compounds that were significantly associated with the NSC 132313.

NSC Compound Enrichment Correlation
NSC 677169 Null 5.88106018705558e-006 0.53834503
NSC 726332 6-[3-((2,2-Dimethoxyethylamino)-1-propyl)]-5,6-dihydro-2,3- dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c] isoquinoline 6.13985294021483e-005 0.63055279
NSC 654509 Pirarubicin HCl 6.67967536140751e-005 0.77300585
NSC 683140 Null 6.67967536140751e-005 0.6052774
NSC 691240 Null 6.67967536140751e-005 0.49783359
NSC 758423 Amsacrine (USAN) 6.67967536140751e-005 0.8286915
NSC 736201 Indenoisoquinoline derivative 6.74487631170136e-005 0.76206746
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 6.74487631170141e-005 0.75795824
NSC 750148 3-(2-Hydroxy-5-chloro-4-methylphenyl)-5-(2-phenylethene)-1-(4-sulfamylphenyl)-pyrazoline 7.32098910136557e-006 -0.046146135
NSC 691849 Null 8.45012998844858e-005 0.74732962
Total:90  Current:89    [First] [Prev] [Next] [Last]